Yes, a diagnosis from a licensed Clinical Neuropsychologist, Psychiatrist, or Neurologist using DSM-5 criteria is recognized in the US, Canada, and most of Europe
GIPR is a class B G protein-coupled receptor that mediates the activity of glucose-dependent insulinotropic polypeptide and plays an important role in insulin secretion, energy balance, and metabolic regulation
Below 5mg/mL, oxidative degradation accelerates due to increased air-peptide surface contact
Additional cardiovascular benefits may be provided by combination therapy with other antidiabetic medications, such as SGLT2 inhibitors
However, participants were only followed for 12 weeks in both studies